socalTECH

JANUARY 17, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. and $16.00

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

JANUARY 26, 2017

Anaptys priced its IPO on Wednesday night at $15.00 AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. The company now trades as ANAB on the NASDAQ Global Select Market. per share, at the midpoint of its $14.00

Avalon 100

Avalon San Diego Pricing Invest 100

socalTECH

SEPTEMBER 19, 2008

We seem to receive lots of pitches from companies looking to attack the mobile market with their mobile software applications, but few who have deployed on-deck with carriers. in funding from Venrock, Avalon, and Masthead. Derrick Oien: The primary market is the operator. Intercasting is backed by $17.5M

Social Network 113

Social Network Anthem Mobile Java 113